Recent advances in CRISPR-Cas9 technology have focused on improving its accuracy and efficiency. Innovations such as high-fidelity Cas9 variants and base editing techniques aim to minimize off-target effects. Researchers are also developing new delivery methods, including viral vectors and nanoparticles, to enhance the system's ability to reach cancer cells in vivo.
